Clinical trials: Natural Daylight Photodynamic Therapy
Actinic Keratoses
Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses
This study was to be conducted as a multi-centre, randomized, investigator-blinded, active and vehicle-controlled, intra-individual (split-face/scalp) non-inferiority (regarding efficacy) and superiority (regarding pain) study.
- Trial name
- COMET2 (NCT01821391)
- Testing
- NDL-PDT, c-PDT
- Where
- 18 sites in France, Germany and 3 more
- Volunteers
- 131 people
- Sponsor
- Galderma R&D
Actinic Keratoses
Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy with Aktilite™ lamp in subjects with mild actinic…
- Trial name
- CoMet (NCT01475071)
- Testing
- Metvix and natural daylight PDT, Metvix and conventional PDT
- Where
- 6 sites in Australia
- Volunteers
- 100 people
- Sponsor
- Galderma R&D